Literature DB >> 28521488

miR-137 inhibits the proliferation of human non-small cell lung cancer cells by targeting SRC3.

Ruilin Chen1, Yongqing Zhang1, Chengcheng Zhang1, Hua Wu1, Shumei Yang1.   

Abstract

Non-small cell lung cancer (NSCLC) is the most common type of lung cancer. The results of the present study demonstrate that high expression of microRNA (miR)-137 and low expression of steroid receptor coactivator-3 (SRC3) had a significant negative correlation in 40 NSCLC tissue samples. In addition, cell colony formation and proliferation was significantly reduced in miR-137-transfected A549 and NCI-H838 cells compared with scramble-transfected NSCLC cell lines. miR-137 was identified to induce G1/S cell cycle arrest and dysregulate the mRNA expression of cell cycle-associated proteins (proliferating cell nuclear antigen, cyclin E, cyclin A1, cyclin A2 and p21) in NSCLC cells. Notably, miR-137 could significantly suppress SRC3 3' untranslated region (UTR) luciferase-reporter activity, an effect that was not detectable when the putative 3'-UTR target-site was mutated, further clarifying the molecular mechanisms underlying the role of miR-137 in NSCLC. In conclusion, the results of the present study suggest that miR-137 suppresses NSCLC cell proliferation by partially targeting SRC3.

Entities:  

Keywords:  cell proliferation; miR-137; non-small cell lung cancer cells; steroid receptor coactivator-3

Year:  2017        PMID: 28521488      PMCID: PMC5431322          DOI: 10.3892/ol.2017.5904

Source DB:  PubMed          Journal:  Oncol Lett        ISSN: 1792-1074            Impact factor:   2.967


  35 in total

Review 1.  MicroRNAs: small RNAs with a big role in gene regulation.

Authors:  Lin He; Gregory J Hannon
Journal:  Nat Rev Genet       Date:  2004-07       Impact factor: 53.242

2.  miRNA expression profiling of lung adenocarcinomas: correlation with mutational status.

Authors:  Sanja Dacic; Lindsey Kelly; Yongli Shuai; Marina N Nikiforova
Journal:  Mod Pathol       Date:  2010-09-03       Impact factor: 7.842

3.  miR-218 inhibits the proliferation of glioma U87 cells through the inactivation of the CDK6/cyclin D1/p21Cip1/Waf1 pathway.

Authors:  Gu Jian Jun; Gao Guang Zhong; Zhang Shi Ming
Journal:  Oncol Lett       Date:  2015-03-23       Impact factor: 2.967

4.  Overexpression and gender-specific differences of SRC-3 (SRC-3/AIB1) immunoreactivity in human non-small cell lung cancer: an in vivo study.

Authors:  Haidong Wang; Dongmei Zhang; Wei Wu; Jiqiang Zhang; Deyu Guo; Qingliang Wang; Tao Jing; Chengping Xu; Xiuwu Bian; Kang Yang
Journal:  J Histochem Cytochem       Date:  2010-09-17       Impact factor: 2.479

5.  Extensive modulation of a set of microRNAs in primary glioblastoma.

Authors:  S A Ciafrè; S Galardi; A Mangiola; M Ferracin; C-G Liu; G Sabatino; M Negrini; G Maira; C M Croce; M G Farace
Journal:  Biochem Biophys Res Commun       Date:  2005-09-09       Impact factor: 3.575

6.  microRNA-137 functions as a tumor suppressor in human non-small cell lung cancer by targeting SLC22A18.

Authors:  Bicheng Zhang; Tao Liu; Tingting Wu; Zhigang Wang; Zhiguo Rao; Jianfei Gao
Journal:  Int J Biol Macromol       Date:  2014-12-11       Impact factor: 6.953

7.  Mammalian microRNAs predominantly act to decrease target mRNA levels.

Authors:  Huili Guo; Nicholas T Ingolia; Jonathan S Weissman; David P Bartel
Journal:  Nature       Date:  2010-08-12       Impact factor: 49.962

8.  MiR-135a inhibits migration and invasion and regulates EMT-related marker genes by targeting KLF8 in lung cancer cells.

Authors:  Hongyang Shi; Yuqiang Ji; Dexin Zhang; Yun Liu; Ping Fang
Journal:  Biochem Biophys Res Commun       Date:  2015-07-30       Impact factor: 3.575

9.  Human RAD18 is involved in S phase-specific single-strand break repair without PCNA monoubiquitination.

Authors:  Naoko Shiomi; Masahiko Mori; Hideo Tsuji; Takashi Imai; Hirokazu Inoue; Satoshi Tateishi; Masaru Yamaizumi; Tadahiro Shiomi
Journal:  Nucleic Acids Res       Date:  2006-12-07       Impact factor: 16.971

10.  Dysfunctions associated with methylation, microRNA expression and gene expression in lung cancer.

Authors:  Tao Huang; Min Jiang; Xiangyin Kong; Yu-Dong Cai
Journal:  PLoS One       Date:  2012-08-17       Impact factor: 3.240

View more
  10 in total

1.  Regulatory interactions between long noncoding RNA LINC00968 and miR-9-3p in non-small cell lung cancer: A bioinformatic analysis based on miRNA microarray, GEO and TCGA.

Authors:  Dong-Yao Li; Wen-Jie Chen; Jun Shang; Gang Chen; Shi-Kang Li
Journal:  Oncol Lett       Date:  2018-04-12       Impact factor: 2.967

2.  Circular RNA circ-LDLRAD3 serves as an oncogene to promote non-small cell lung cancer progression by upregulating SLC1A5 through sponging miR-137.

Authors:  Min Xue; Weijun Hong; Jun Jiang; Fang Zhao; Xiwen Gao
Journal:  RNA Biol       Date:  2020-07-13       Impact factor: 4.652

3.  HAS2-AS1 Acts as a Molecular Sponge for miR-137 and Promotes the Invasion and Migration of Glioma Cells by Targeting EZH2.

Authors:  Juntong Wang; Yuyan Zhang; Aiwu You; Jun Li; Jingshun Gu; Guomin Rao; Xuehua Ge; Kun Zhang; Haoyu Fu; Xiaohui Liu; Jianfeng Li; Qianchao Wang; Xiaotang Wu; Ling Cheng; Mengjiao Zhu; Dongchun Wang
Journal:  Cell Cycle       Date:  2020-10-16       Impact factor: 4.534

Review 4.  Why Be One Protein When You Can Affect Many? The Multiple Roles of YB-1 in Lung Cancer and Mesothelioma.

Authors:  Thomas G Johnson; Karin Schelch; Sunali Mehta; Andrew Burgess; Glen Reid
Journal:  Front Cell Dev Biol       Date:  2019-10-01

5.  Identification of Key Genes Related to Lung Squamous Cell Carcinoma Using Bioinformatics Analysis.

Authors:  Miaomiao Gao; Weikaixin Kong; Zhuo Huang; Zhengwei Xie
Journal:  Int J Mol Sci       Date:  2020-04-23       Impact factor: 5.923

6.  miR-137 alleviates doxorubicin resistance in breast cancer through inhibition of epithelial-mesenchymal transition by targeting DUSP4.

Authors:  Feiya Du; Ling Yu; Ying Wu; Shuqian Wang; Jia Yao; Xiaoxiao Zheng; Shangzhi Xie; Shufeng Zhang; Xuemei Lu; Yu Liu; Wei Chen
Journal:  Cell Death Dis       Date:  2019-12-04       Impact factor: 8.469

7.  Upregulation of miR-137 Expression Suppresses Tumor Growth and Progression via Interacting with DNMT3a Through Inhibiting the PTEN/Akt Signaling in HCC.

Authors:  Jiachen Wang; Zhao Wang; Jiaxiang Yuan; Qun Wang; Xinsheng Shen
Journal:  Onco Targets Ther       Date:  2021-01-08       Impact factor: 4.147

8.  Ferroptosis-related gene SLC1A5 is a novel prognostic biomarker and correlates with immune infiltrates in stomach adenocarcinoma.

Authors:  Dandan Zhu; Sifan Wu; Yafang Li; Lixue Cao; Zejian Lyu; Tieying Hou; Yu Zhang; Jierong Chen; Jianhong Ma
Journal:  Cancer Cell Int       Date:  2022-03-19       Impact factor: 5.722

9.  miR-137 regulates ferroptosis by targeting glutamine transporter SLC1A5 in melanoma.

Authors:  Meiying Luo; Longfei Wu; Kexin Zhang; Hong Wang; Tian Zhang; Lucas Gutierrez; Douglas O'Connell; Peng Zhang; Yu Li; Tongtong Gao; Wenyan Ren; Yongfei Yang
Journal:  Cell Death Differ       Date:  2018-01-18       Impact factor: 15.828

10.  Identification of key genes associated with progression and prognosis for lung squamous cell carcinoma.

Authors:  Xiaohan Ma; Huijun Ren; Ruoyu Peng; Yi Li; Liang Ming
Journal:  PeerJ       Date:  2020-05-06       Impact factor: 2.984

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.